All In Biotech

Free tool

FAERS Monitor: Ammonia N 13

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 21, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 022119 or its brand name (Ammonia N 13, Ammonia N-13). Reports on generic versions are filed under their own applications.

Reports

57

Serious

43

75% of reports

Hospitalization

25

Death reported

8

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug abuse7
  • cough6
  • depression6
  • drug ineffective6
  • chest pain5
  • dyspnoea5
  • nausea5
  • suicide attempt5
  • vomiting5
  • accidental exposure to product4
  • drug hypersensitivity4
  • eye irritation4
  • eye pruritus4
  • gastritis4
  • loss of personal independence in daily activities4

Reports by year received

View as table
YearReports
20051
20073
20101
20113
20121
20133
20142
20153
20164
20171
20185
20196
20203
20213
20222
20233
20243
20259
20261

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,102 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
gastritisSignal456.121.8165
eye pruritusSignal443.917.1128
drug abuseSignal731.015.5175
loss of personal independence in daily activitiesSignal430.711.987
suicide attemptSignal530.413.2115
eye irritationSignal425.610.072
accidental exposure to productSignal414.35.637
chest painSignal510.04.332
depressionSignal69.74.639
coughSignal67.93.730
drug hypersensitivitySignal47.63.017
vomitingSignal53.91.78
dyspnoeaSignal53.31.46
nausea52.31.03
drug ineffective61.70.81

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.